Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
8.11
-0.11 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
8.14
0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT
Gyre Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 36.49M | 15.04M | 11.81M | 15.87M | 16.1M | 29.79M | 33.51M | 2.23M | 6.92M | 8.1M | 21.67M | 23.09M | 75.39M | 34.82M | 44.35M | 59.16M | 73.62M | 83.04M |
Short-Term Investments | 17.87M | 14.85M | 14.86M | 9.23M | 9M | 7.57M | n/a | n/a | 258.42K | 607.39K | n/a | n/a | n/a | n/a | 2.5M | 5.37M | 12.9M | 23.96M |
Long-Term Investments | n/a | 21.37M | 24.57M | 29.52M | 33.64M | 23.11M | 23.43M | 4.66M | 4.61M | 4.55M | 7.39M | 7.39M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 26.86M | 5.56M | 3.03M | 9.14M | 1.28M | 5.58M | 10.41M | 4.83M | 4.77M | -24.79M | 168K | 168K | 168K | 472K | 472K | 869K | 1.17M | 528K |
Receivables | 25.36M | 22.52M | 29.15M | 20.77M | 19.91M | 16.75M | 15.16M | 1.2M | 300K | 5M | 5M | 5M | 5M | 564K | 1.82M | 1.11M | 1.97M | 1.01M |
Inventory | 8.86M | 7.88M | 6.34M | 6.38M | 5.63M | 4.94M | 4.28M | 1.17M | 5.26M | 5.68M | 6.12M | 6.12M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 20.57M | n/a | 1.44M | 1.51M | 1.72M | 1.9M | 2.72M | 535K | 397K | 915K | 1.54M | 2.16M | 914K | 1.32M | 2.81M | 8.32M | 8.33M | 8.51M |
Total Current Assets | 91.28M | 68.45M | 64.79M | 54.81M | 53.52M | 62.72M | 57.22M | 5.13M | 7.62M | 14.01M | 28.21M | 30.25M | 81.31M | 36.7M | 51.48M | 73.96M | 96.83M | 116.52M |
Property-Plant & Equipment | 23.4M | 23.52M | 25.7M | 26.43M | 25.77M | 23.92M | 23.78M | 23.78M | 21.89M | 18K | 70K | 605K | 1.9M | 3.1M | 3.71M | 3.7M | 3.79M | 2.03M |
Goodwill & Intangibles | 4.96M | 5.08M | 1.71M | 184K | 1.65M | 1.68M | 1.7M | 1.7M | 25.03M | 24.55M | 1.86M | 1.86M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 61.36M | 61.34M | 60.62M | 70.43M | 67.41M | 59.29M | 59.32M | 4.83M | 4.77M | 4.74M | 238K | 773K | 2.06M | 3.57M | 4.19M | 4.57M | 4.96M | 2.56M |
Total Assets | 152.65M | 129.79M | 125.41M | 125.24M | 120.93M | 122.01M | 116.54M | 9.96M | 12.39M | 18.75M | 28.44M | 31.02M | 83.37M | 40.27M | 55.66M | 78.54M | 101.79M | 119.08M |
Account Payables | 71K | 122K | 108K | 303K | 271K | 330K | 355K | 158K | 5K | 16K | 194K | 41K | 1.04M | 4.71M | 6.42M | 3.86M | 1.83M | 2.96M |
Deferred Revenue | n/a | 123K | 156K | 36K | 97K | 75K | n/a | n/a | n/a | -506.55K | n/a | n/a | n/a | n/a | 230K | 853K | 2.04M | 1.33M |
Short-Term Debt | 622K | n/a | 713K | 694K | 659K | 100K | n/a | n/a | n/a | n/a | 38K | 381K | 1.42M | 1.91M | 1.98M | 1.84M | 1.81M | 678K |
Other Current Liabilities | 15.14M | 3K | 4.99M | 3.49M | 8.17M | 6.45M | 9.83M | 917K | 2.79M | 5.74M | 9.33M | -310K | 1.86M | 6.58M | 5.54M | 10.69M | 9.88M | 9.21M |
Total Current Liabilities | 16.92M | 18.99M | 19.52M | 14.72M | 15.57M | 19.49M | 20.05M | 1.78M | 2.79M | 6.84M | 16.82M | 1.64M | 4.31M | 13.19M | 14.16M | 17.25M | 15.57M | 14.18M |
Long-Term Debt | 771K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.62K | n/a | n/a | n/a | n/a | n/a | 408K | 550K | 1.05M | 806K |
Other Long-Term Liabilities | 4.63M | 4.81M | 5.67M | 10.76M | 10.52M | 13.38M | 17.61M | 4.46M | 37.91M | 37.86M | 33.19M | -121K | n/a | n/a | -408K | -550K | -1.05M | -806K |
Total Long-Term Liabilities | 6.28M | 6.5M | 7.49M | 12.05M | 12.01M | 13.75M | 18.02M | 4.66M | 37.91M | 37.86M | 33.31M | 422K | n/a | n/a | 408K | 550K | 1.05M | 806K |
Total Liabilities | 23.2M | 25.49M | 27M | 26.77M | 27.58M | 33.24M | 38.06M | 6.45M | 40.71M | 44.7M | 50.13M | 1.64M | 4.31M | 13.19M | 14.57M | 17.8M | 16.62M | 14.99M |
Total Debt | 1.39M | 1.58M | 1.6M | 1.79M | 1.96M | 275K | 409K | 199K | 2.62K | 4.55M | 38K | 381K | 1.42M | 1.91M | 2.38M | 2.39M | 2.87M | 1.48M |
Common Stock | 91K | 87K | 86K | 85K | 85K | 85K | 77K | 37K | 37K | 37K | 37K | 31K | 31K | 31K | 31K | 31K | 31K | 31K |
Retained Earnings | -70.31M | -70.75M | -73.45M | -73.35M | -74.48M | -78.01M | -85.54M | -414.72M | -413.15M | -410.68M | -410.94M | -370.48M | -365.6M | -417.23M | -402.69M | -382.37M | -357.13M | -337.2M |
Comprehensive Income | -2.29M | 612K | 501K | -946K | 1.09M | 1.36M | 1.45M | n/a | -33.31M | 40.88M | -33.31M | -392K | n/a | n/a | n/a | 1K | 2K | 5K |
Shareholders Equity | 92.03M | 68.12M | 63.32M | 63.18M | 60.35M | 56.64M | 48.7M | 3.52M | -28.31M | -25.95M | -21.69M | 29.38M | 79.06M | 27.08M | 41.09M | 60.74M | 85.16M | 104.09M |
Total Investments | 17.87M | 36.21M | 39.43M | 38.74M | 42.64M | 30.67M | 23.43M | 4.66M | 4.61M | 4.55M | 7.39M | 7.39M | n/a | n/a | 2.5M | 5.37M | 12.9M | 23.96M |